These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1031 related articles for article (PubMed ID: 18164978)

  • 41. Synthesis and structure-activity relationship studies of cytotoxic anhydrovinblastine amide derivatives.
    Shao Y; Zhang HK; Ding H; Quan HT; Lou LG; Hu LH
    J Nat Prod; 2009 Jun; 72(6):1170-7. PubMed ID: 19499938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of novel pyrimidine-2,4-diones and 2-thioxo-pyrimidine-4-ones as potential anticancer and antimicrobial agents.
    Soliman R; Habib NS; Ismail K; Moustafa A; Sarg MT; Fanaki NH
    Boll Chim Farm; 2003 May; 142(4):167-74. PubMed ID: 12918226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives.
    Gürsoy E; Güzeldemirci NU
    Eur J Med Chem; 2007 Mar; 42(3):320-6. PubMed ID: 17145120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and structure-activity relationships of antiproliferative 1,3-disubstituted urea derivatives.
    Li HQ; Zhu TT; Yan T; Luo Y; Zhu HL
    Eur J Med Chem; 2009 Feb; 44(2):453-9. PubMed ID: 18514972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation, characterization & anticancer evaluation of potassium N-(p-anisole)-alpha-(2-xanthatophenyl)nitrone.
    Khallow KI; Ezzat SS; al-Omari NA
    Boll Chim Farm; 2002; 141(6):447-52. PubMed ID: 12577515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemisynthetic secofriedelane triterpenes with inhibitory activity against the growth of human tumor cell lines in vitro.
    Moiteiro C; Manta C; Justino F; Tavares R; Curto MJ; Pedro M; Nascimento MS; Pinto M
    J Nat Prod; 2004 Jul; 67(7):1193-6. PubMed ID: 15270581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
    Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
    Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
    Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
    J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives.
    Kolokythas G; Pouli N; Marakos P; Pratsinis H; Kletsas D
    Eur J Med Chem; 2006 Jan; 41(1):71-9. PubMed ID: 16300857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation.
    Rosowsky A; Vaidya CM; Bader H; Wright JE; Teicher BA
    J Med Chem; 1997 Jan; 40(3):286-99. PubMed ID: 9022795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
    Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
    Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
    Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
    Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and cytotoxicity of 2-acetyl-4,8-dihydrobenzodithiophene-4, 8-dione derivatives.
    Chao YH; Kuo SC; Wu CH; Lee CY; Mauger A; Sun IC; Morris-Natschke SL; Lee KH
    J Med Chem; 1998 Nov; 41(23):4658-61. PubMed ID: 9804705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
    Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
    J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, cytotoxicity, and structure-activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent.
    Das B; Chowdhury C; Kumar D; Sen R; Roy R; Das P; Chatterjee M
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6947-50. PubMed ID: 20974534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids.
    Malhotra SV; Kumar V
    Bioorg Med Chem Lett; 2010 Jan; 20(2):581-5. PubMed ID: 20006501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design of beta-carboline derivatives as DNA-targeting antitumor agents.
    Guan H; Chen H; Peng W; Ma Y; Cao R; Liu X; Xu A
    Eur J Med Chem; 2006 Oct; 41(10):1167-79. PubMed ID: 16790297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety.
    Ragab FAF; Abou-Seri SM; Abdel-Aziz SA; Alfayomy AM; Aboelmagd M
    Eur J Med Chem; 2017 Sep; 138():140-151. PubMed ID: 28667871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
    Teng CH; Won SJ; Lin CN
    Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.